Prolaktin - Hormon med många effekter

Lakartidningen

Volumn 96, Issue 10, 1999, Pages 1171-1174

  Werner, Sigbritt ^a   Bengtsson, Bengt Åke ^b   Petruson, Björn ^b   Karlsson, Anders ^c   Bolander, Hans ^c   Bramnert, Margareta ^d   Valdemarsson, Stig ^e   Bynke, Olof ^f   Öhman, Peter ^f   Olsson, Tommy ^g   Rasmuson, Torgny ^g   Änggård, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d Malmö Allmänna Sjukhus   (Sweden)

^e Universitetsjukhuset i Lund ^*  (Sweden)

^f LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

ANIMAL; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; MALE; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PROLACTINOMA; REVIEW; SECRETION;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; MALE; PITUITARY NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROLACTIN; PROLACTINOMA;

EID: 0033540877     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lindstedt G, Edén S. Antikroppar mot prolaktin - »Ny» orsak till hyperprolaktinemi. Lakartidningen 1994; 91: 2833-4.
2. Erskin M. Prolactin release after mating and genitosensory stimulation in females. Endocrine Reviews 1995; 10: 508-28.
3. Sinha YN. Structural variants of prolactin: Occurrence and physiological significance. Endocrine Reviews 1995; 16: 354-69,.
4. Wennbo H, Kindblom J, Isaksson OGP, Tömell J. Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 1998; 138: 4410-5.
5. Wilson III DM, Emanuele NV, Halloran MM, Tentler JJ, Lawerence AM, Kelley MR. Prolactin message in brain and pituitary of adult male rats is identical. PCR cloning and sequencing of hypothalamic prolactin cDNA from intact and hypophysectomized adult male rats. Endocrinology 1992; 131: 2488-90.
6. Gellersen B, DiMattia GE, Friesen HG, Bohnet HG. Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript. Mol Cell Endocrinol 1989; 64: 127-30.
7. Postel-Vinay MC, Kayser C, Kelly PA, Djiane J. Identification of prolactin and growth hormone binding proteins in rabbit milk. Proc Natl Acad Sci USA 1991; 88: 6687-90.
8. Larrea F, Martinez-Castillo A, Cabrera V, Alcocer-Varela J, Quiepo G, Carino C et al. A bioactive 60-kilodalton prolactin species is secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab 1997; 82: 3664-9.
9. Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG et al. A new cytokine receptor superfamily. Trends Biochem Sci 1990; 15: 265-70.
10. Carlson HE, Markoff E, Lee DW. On the nature of serum prolactin in two patients with macroprolactinemia. Fertil Steril 1992; 58: 78-87.
11. Colao AM, Di Sarno A, Sarnacchiaro F, Ferone D, Di Renzo G, Merola B et al. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab 1997; 82: 876-83.
12. Webster J, Piscitelli G, Polli A, Ferrari C, Ismail J, Scanlon M. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 1994; 331: 904-9.
13. Kauppila A, Chatelain P, Kirkinen P, Kivinen S. Isolated PRL deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab 1987; 64: 309-12.
14. Edal AL, Skjödt K, Nepper-Rasmussen HJ. SIPAP - a new MR classification for pituitary adenomas. Acta Radiol 1997; 38: 30-6.